1. A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritis. Issue 3 (13th September 2016) Authors: Yoo, Dae Hyun; Suh, Chang-Hee; Shim, Seung Cheol; Jeka, Slawomir; Cons-Molina, Francisco Fidencio; Hrycaj, Pawel; Wiland, Piotr; Lee, Eun Young; Medina-Rodriguez, Francisco G; Shesternya, Pavel; Radominski, Sebastiao; Stanislav, Marina; Kovalenko, Volodymyr; Sheen, Dong Hyuk; Myasoutova, Leysan; ... Journal: Annals of the rheumatic diseases Issue: Volume 76:Issue 3(2017) Page Start: 566 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study. Issue 10 (16th May 2013) Authors: Park, Won; Hrycaj, Pawel; Jeka, Slawomir; Kovalenko, Volodymyr; Lysenko, Grygorii; Miranda, Pedro; Mikazane, Helena; Gutierrez-Ureña, Sergio; Lim, MieJin; Lee, Yeon-Ah; Lee, Sang Joon; Kim, HoUng; Yoo, Dae Hyun; Braun, Jürgen Journal: Annals of the rheumatic diseases Issue: Volume 72:Issue 10(2013) Page Start: 1605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study. Issue 10 (16th May 2013) Authors: Yoo, Dae Hyun; Hrycaj, Pawel; Miranda, Pedro; Ramiterre, Edgar; Piotrowski, Mariusz; Shevchuk, Sergii; Kovalenko, Volodymyr; Prodanovic, Nenad; Abello-Banfi, Mauricio; Gutierrez-Ureña, Sergio; Morales-Olazabal, Luis; Tee, Michael; Jimenez, Renato; Zamani, Omid; Lee, Sang Joon; Kim, HoUng; Park, W... Journal: Annals of the rheumatic diseases Issue: Volume 72:Issue 10(2013) Page Start: 1613 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: results of an exploratory randomised MRI study incorporating semiquantitative and quantitative techniques. Issue 6 (25th January 2016) Authors: Conaghan, Philip G; Østergaard, Mikkel; Bowes, Michael A; Wu, Chunying; Fuerst, Thomas; van der Heijde, Désirée; Irazoque-Palazuelos, Fedra; Soto-Raices, Oscar; Hrycaj, Pawel; Xie, Zhiyong; Zhang, Richard; Wyman, Bradley T; Bradley, John D; Soma, Koshika; Wilkinson, Bethanie Journal: Annals of the rheumatic diseases Issue: Volume 75:Issue 6(2016) Page Start: 1024 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial. Issue 6 (18th August 2018) Authors: Park, Won; Božić-Majstorović, Ljubinka; Milakovic, Dragana; Berrocal Kasay, Alfredo; El-Khouri, Elias Chalouhi; Irazoque-Palazuelos, Fedra; Molina, Francisco Fidencio Cons; Shesternya, Pavel; Miranda, Pedro; Medina-Rodriguez, Francisco G.; Wiland, Piotr; Jeka, Slawomir; Chavez-Corrales, Jose; Gar... Journal: MAbs Issue: Volume 10:Issue 6(2018) Page Start: 934 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial. (10th June 2019) Authors: Shim, Seung Cheol; Božić-Majstorović, Ljubinka; Berrocal Kasay, Alfredo; El-Khouri, Elias Chalouhi; Irazoque-Palazuelos, Fedra; Cons Molina, Francisco Fidencio; Medina-Rodriguez, Francisco G; Miranda, Pedro; Shesternya, Pavel; Chavez-Corrales, Jose; Wiland, Piotr; Jeka, Slawomir; Garmish, Olena; ... Journal: Rheumatology Issue: Volume 58:Number 12(2019) Page Start: 2193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence study. Issue 10 (5th June 2017) Authors: Cohen, Stanley; Genovese, Mark C; Choy, Ernest; Perez-Ruiz, Fernando; Matsumoto, Alan; Pavelka, Karel; Pablos, Jose L; Rizzo, Warren; Hrycaj, Pawel; Zhang, Nan; Shergy, William; Kaur, Primal Journal: Annals of the rheumatic diseases Issue: Volume 76:Issue 10(2017) Page Start: 1679 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Interleukin‐17 and interleukin‐23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis. (28th January 2014) Authors: Olewicz‐Gawlik, Anna; Danczak‐Pazdrowska, Aleksandra; Kuznar‐Kaminska, Barbara; Gornowicz‐Porowska, Justyna; Katulska, Katarzyna; Trzybulska, Dorota; Batura‐Gabryel, Halina; Silny, Wojciech; Poplawski, Dariusz; Hrycaj, Pawel Journal: International journal of rheumatic diseases Issue: Volume 17:Number 6(2014) Page Start: 664 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Interleukin‐17 and interleukin‐23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis. (28th January 2014) Authors: Olewicz‐Gawlik, Anna; Danczak‐Pazdrowska, Aleksandra; Kuznar‐Kaminska, Barbara; Gornowicz‐Porowska, Justyna; Katulska, Katarzyna; Trzybulska, Dorota; Batura‐Gabryel, Halina; Silny, Wojciech; Poplawski, Dariusz; Hrycaj, Pawel Journal: International journal of rheumatic diseases Issue: Volume 17:Number 6(2014) Page Start: 664 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Sarilumab and Nonbiologic Disease‐Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis and Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors. Issue 2 (28th January 2017) Authors: Fleischmann, Roy; van Adelsberg, Janet; Lin, Yong; Castelar‐Pinheiro, Geraldo da Rocha; Brzezicki, Jan; Hrycaj, Pawel; Graham, Neil M. H.; van Hoogstraten, Hubert; Bauer, Deborah; Burmester, Gerd R. Journal: Arthritis & rheumatology Issue: Volume 69:Issue 2(2017) Page Start: 277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗